The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tolerability of and biochemical control of permanent pd-103 brachytherapy followed by external beam radiotherapy for localized prostate adenocarcinoma.
Samuel M. Richter
No relevant relationships to disclose
Paul D. Aridgides
No relevant relationships to disclose
Oleg Shapiro
No relevant relationships to disclose
Jesse N. Aronowitz
No relevant relationships to disclose
Jeffrey Bogart
No relevant relationships to disclose